|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 493 articles |
 Page 1 of 7 
|
Abbott posts 10.2% sales growth for 3rd-qtr 2004, led by arthritis dru...
October 25, 2004
Endo's shares jump on 3rd-qtr results.(Brief Article)
October 25, 2004
MGI's 3rd-qtr losses rocket on acquisitions.(Brief Article)
October 25, 2004
Disclose Rx AEs before licensing, says study.(adverse events)(Brief Ar...
October 25, 2004
Russia to tighten Rx quality controls.(Brief Article)
October 25, 2004
Italy to fully reimburse 35 new medicines.(Associazione Italiana Famig...
October 25, 2004
Turkish drug prices stable.(Brief Article)
October 25, 2004
World drug sales up 8% in year to August 2004.
October 25, 2004
New cancer drug costs too high for some?
October 25, 2004
Pharma industry reports from Research & Markets.(Brief Article)
October 25, 2004
TxCell raises 10.5M euros in Series A round.(Brief Article)
October 25, 2004
Genetics Co opens first Alzheimer's reference center.(Brief Article)
October 25, 2004
Pharmaceutical industry R&D crisis obscured by industry consolidation,...
October 25, 2004
Teranode unveils first closed-loop R&D platform.(Teranode Corp )(Brief...
October 25, 2004
US patent granted to Entropin.(Brief Article)
October 25, 2004
Vectura completes first development phase for GyroHaler.(Brief Article...
October 25, 2004
Maxim restructures to cut burn rate.(Brief Article)
October 25, 2004
Tokyo pharma stocks - week to October 18.
October 25, 2004
Spanish pharma slams govt statements over "expensive" drug Rxing.(Brie...
October 25, 2004
German pharma unease at govt intervention.(Brief Article)
October 25, 2004
German public-sector Rx costs down in 2003.(Brief Article)
October 25, 2004
Spanish Rx prices stable.(Brief Article)
October 25, 2004
Merck & Co says study shows Arcoxia is safe.(Brief Article)
October 25, 2004
Roche licenses Japan Tobacco's JTT-705.(JTT-705)(Brief Article)
October 25, 2004
BioCryst's oral form of forodesine enters clinic.(Brief Article)
October 25, 2004
High hopes for vacc storage technology.(Brief Article)
October 25, 2004
Neurocrine files indiplon NDA.(Brief Article)
October 25, 2004
ViroPharma acquires US Vancocin brand.(Brief Article)
October 25, 2004
Akzo Nobel sees 3rd-qtr 2004 profits soar.(Brief Article)
October 25, 2004
ViroLogic and Aclara revise merger terms.(Brief Article)
October 25, 2004
bioMerieux posts 5.6% rise in nine-month sales.(Brief Article)
October 25, 2004
Novartis staff "told to use generics, OTCs".(Brief Article)
October 25, 2004
Pfizer's 3rd-qtr 2004 results exceed expectations as earnings leap 50%...
October 25, 2004
Nabi's 3rd-qtr 2004 profit takes a dive.(Brief Article)
October 25, 2004
KWS and BioDynamics sign marketing deal.(BioDynamics Research)(Brief A...
October 25, 2004
The Medicines Co sees 3rd-qtr sales rocket 77%.(Brief Article)
October 25, 2004
Synairgen raises L10.5M on AIM.(Brief Article)
October 25, 2004
Wyeth swings to 3rd-qtr profit of $1.42B, after like-qtr loss of $425....
October 25, 2004
Data on new ED drug hope from Dong-A PharmTech.
October 25, 2004
Exelixis completes X-Ceptor acquisition.(Brief Article)
October 25, 2004
ImmuCell's 3rd-qtr product sales grow 8%.(Brief Article)
October 25, 2004
PDi to promote Shionogi antibiotic in USA.
October 25, 2004
Rolf Hoffmann joins Amgen as senior VP, European operations.(Brief Art...
October 25, 2004
Elan denies merger talks with Biogen Idec.(Brief Article)
October 25, 2004
VaxGen names Kathrin Jansen senior VP, R&D.(Brief Article)
October 25, 2004
Inyx buys Aventis assets in Puerto Rico.(Brief Article)
October 25, 2004
Phase I results for PTC Thera's PTC124.(Brief Article)
October 25, 2004
Nobex and Biocon in oral insulin deal.(Brief Article)
October 25, 2004
Orphan Drug status for Kosan's 17-AAG for multiple myeloma.(Brief Arti...
October 25, 2004
New data for Amgen/Wyeth's Enbrel at ACR.(Brief Article)
October 25, 2004
VaxGen starts Ph I/II testing for its smallpox vaccine.
October 25, 2004
Benitec licenses RNAi delivery tech from Stanford University.(Brief Ar...
October 25, 2004
Pozen names Marshall Reese exec VP, product development.(Brief Article...
October 25, 2004
Naveen Anand joins Hybridon as VP, corporate and business development....
October 25, 2004
Progenics names Alton Kremer as VP, clinical research.(Brief Article)
October 25, 2004
Eric von Hofe promoted at Generex.(Brief Article)
October 25, 2004
Lek opens new production unit in Slovenia.(Brief Article)
October 25, 2004
UCB promotes Luc Missorten to CFO.(Brief Article)
October 25, 2004
Amgen sees 3rd-qtr earnings climb 21% but profit drops; lifts outlook ...
October 25, 2004
SPECTRUM.(Brief Article)(Illustration)
October 25, 2004
Stock Commentary - Europe.(Brief Article)
October 25, 2004
Stock Commentary - New York.
October 25, 2004
Schering AG's three-qtr EPS rises 12%.(Brief Article)
October 25, 2004
Novartis nine-month net income leaps 21%.(Brief Article)
October 25, 2004
Positive results for deCODE's DG031.(Brief Article)
October 25, 2004
Second pivotal study for Corcept's Corlux.(Brief Article)
October 25, 2004
Mylan lowers 2nd-qtr earnings forecast.(Brief Article)
October 25, 2004
Barr completes sales force integration.(Barr Pharmaceutical)(Duramed P...
October 25, 2004
Alpharma forecasts loss for 3rd qtr.(Brief Article)
October 25, 2004
Italy's BioXell raises 23M euros in private placing.(Brief Article)
October 25, 2004
FDA OKs ev3's Protege long stents.(Food and Drug Administration)(ev3 I...
October 25, 2004
FDA priority review for Cellegy's Cellegesic.(Food and Drug Administra...
October 25, 2004
Expanded US use for Serono's Luveris.(Brief Article)
October 25, 2004
S-P's Remicade: EU OK for psoriatic arthritis.(European Union)(Brief A...
October 25, 2004
Chiron submits NDA for Pulminiq.(New Drug Approval)(Brief Article)
October 25, 2004
|
1